Japan · Clinical Trials startup
Japan · Renascience
Renascience is a pharmaceuticals company.
Funding reportedLast round: Series B
What company datasets say Renascience raised
Funding, as reported
Reported in all901Min the source's currency
Rounds3
Last roundSeries B
Last round dateMar 2019
Investors listed6
Founders and team
From Renascience's own website: 5 on the team.
- Mituaki Kamata/ Executive Vice President
- Toshio Miyata/ Chairman and CEO
- Akihiko Ito/ Outside Director（Audit & Supervisory Committee Member）
- Hiroaki Nogi/ Outside Director（Audit & Supervisory Committee Member）
- Satoshi Kitaura/ Outside Director（Audit & Supervisory Committee Member）
On a portfolio page
Investors who name them
Each firm lists Renascience on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Clinical Trials in Japan
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Renascience in front of investors. Or tell us what we have wrong.